alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › lumipulse

lumipulse

7 studies tagged lumipulse, dated 2021-01-12 to 2024-08-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 2024-08-22
  2. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms 2024-04-23
  3. Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform 2024-01-01

Studies

7 studies carry this tag.

Date range

2021 to 2024

Top journals

  • Alzheimer's & dementia (Amsterdam, Netherlands) 1
  • Alzheimer's research & therapy 1
  • Annals of clinical and translational neurology 1
  • Frontiers in aging neuroscience 1
  • International journal of molecular sciences 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neurobiology of aging 2024-08-22 Biomarkers

    One-hundred-thirthy-three participants, namely 55 A+T+N+ AD, 28 Neurodegenerative disorders (NDD) and 50 controls were enrolled for the study.

  2. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. International journal of molecular sciences 2024-04-23 Biomarkers

    We compared the clinical and analytical performance of Alzheimer's disease (AD) plasma biomarkers measured using the single-molecule array (Simoa) and Lumipulse platforms.

  3. Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. The journal of prevention of Alzheimer's disease 2024-01-01 Biomarkers

    Plasma p-tau217 measured using the Lumipulse platform shows promise as an accurate biomarker of preclinical AD pathology.

  4. Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE® system

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Annals of clinical and translational neurology 2022-11-02 Biomarkers

    CSF biomarkers measured with the LUMIPULSE system showed good agreement with amyloid PET imaging.

  5. Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Frontiers in aging neuroscience 2021-03-04 Biomarkers

    Manual ELISA assays are the most commonly used methods for quantification of biomarkers; however, they often show inter- and intra-laboratory variability that limits their wide use.

  6. Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2021-02-06 Biomarkers

    The Lumipulse platform provides comparable sensitivity and specificity to established CSF immunoassays in identifying pre-symptomatic AD pathology.

  7. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Alzheimer's research & therapy 2021-01-12 Biomarkers

    Cognitive and neuropsychological scores differed significantly among the groups, with descending performance among CN>SCD>MCI>AD.

All topic tags with their study counts